Immediate and Late Airway Response of Allergic Rhinitis Patients to Segmental Antigen Challenge: Characterization of Eosinophil and Mast Cell Mediators
- 1 December 1991
- journal article
- Published by American Thoracic Society in American Review of Respiratory Disease
- Vol. 144 (6) , 1274-1281
- https://doi.org/10.1164/ajrccm/144.6.1274
Abstract
Segmental antigen bronchoprovocation was used to define the nature of the inflammatory process in allergic airway disease. Bronchoalveolar lavage fluid obtained from allergic rhinitis patients 12 min after segmental antigen instillation (immediate response) revealed a significant increase in histamine and tryptase, but no cellular response. Repeat segmental lavage 48 h later (late response) showed marked and significant increases in both low and normal density eosinophils as well as striking elevations of eosinophil granular protein levels (major basic protein, eosinophil-derived neurotoxin, eosinophil cationic protein, and eosinophil peroxidase). Leukotriene C4, but not tryptase, concentrations were also consistently elevated in late lavage samples. Further, the late lavage samples showed a significant increase in interleukin-5 concentrations that correlated with the presence of eosinophils and eosinophil granular proteins. Neither eosinophils nor soluble mediators of eosinophils increased when normal subjects were similarly challenged with antigen. These data suggest that eosinophils are attracted to the airway during the late-phase allergic reaction and that IL-5 may produce changes in airway eosinophil density and promote the release of granular proteins to cause airway injury.Keywords
This publication has 9 references indexed in Scilit:
- The appearance of hypodense eosinophils during interleukin-2 treatmentJournal of Allergy and Clinical Immunology, 1990
- Intercellular Adhesion Molecule-1 (ICAM-1) in the Pathogenesis of asthmaScience, 1990
- Interleukin 3-dependent and -independent mast cells stimulated with IgE and antigen express multiple cytokines.The Journal of Experimental Medicine, 1989
- Human interleukin-5 (IL-5) regulates the production of eosinophils in human bone marrow cultures: comparison and interaction with IL-1, IL-3, IL-6, and GMCSFBlood, 1989
- Development of a Prolonged Eosinophil-rich Inflammatory Leukocyte Infiltration in the Guinea-Pig Asthmatic Response to Ovalbumin InhalationAmerican Review of Respiratory Disease, 1988
- Recombinant human interleukin 5 is a selective activator of human eosinophil function.The Journal of Experimental Medicine, 1988
- Inflammatory Mediators in Late Antigen-Induced RhinitisNew England Journal of Medicine, 1985
- Elevated serum levels in human pregnancy of a molecule immunochemically similar to eosinophil granule major basic protein.The Journal of Experimental Medicine, 1983
- Standardization of bronchial inhalation challenge proceduresJournal of Allergy and Clinical Immunology, 1975